DarioHealth Signs Leading Functional Medicine Clinic to DarioEngage™ Remote Digital Diabetes Platform

NEW YORK and CAESAREA, Israel, April 1, 2019 /PRNewswire/ — Global #digitaltherapeutics innovator DarioHealth Corp. (Nasdaq: DRIO) today announced an agreement with Cupertino-based Auer Integrative Health’s Functional Medicine and Chiropractic, a Silicon Valley medical clinic.

Auer Integrative, a leader in the U.S., will use the DarioEngage™ healthcare provider platform from DarioHealth to remotely monitor, engage and manage patients with diabetes and pre-diabetes. The platform allows the clinic to support their all-inclusive patient diabetes management program, in which patients receive health and wellness coaching virtually and via phone. Auer Integrative will adopt Dario’s Per Engaged Member, Per Month (PEMPM) business model.

DarioHealth sees clinics as ideal partners to scale up its growth and deliver tangible medical outcomes while providing users with the outstanding experience of diabetes support and lifestyle coaching from their healthcare provider.

“The direct, real-time access to patient blood glucose levels and everyday data related to nutrition and exercise captured by Dario on the patient’s smartphone transforms the ability of our patients to effect better health. Making this information available to our healthcare professionals makes them much more efficient in addressing the most important topics with their patients,” commented Daniel Auer DC, medical director of Auer Integrative. “This is very valuable to us because we can now engage with patients, more effectively, more often, through direct virtual interactions.”

“Chronic illness is the biggest driver of healthcare costs on a national scale as well as on a household scale,” commented Erez Raphael, DarioHealth CEO. “By providing tools that strongly engage the users, enable intuitive lifestyle changes and reduce or delay the impact of diabetes complications, providers are able to deliver better clinical outcomes and meaningfully reduce the costs of chronic illness for the payer and for the individual. Clinical evidence, based on Dario’s data, demonstrates that our superior engagement rates lead to significant and sustainable A1c reduction and increase of in-range glucose measurements.”

For those patients opting out of remote monitoring, the clinic will stock Dario starter kits and products onsite in its Cupertino clinic.

About DarioHealth Corp.

DarioHealth Corp. (Nasdaq: DRIO) is a leading global Digital Therapeutics (DTx) company revolutionizing the way people manage their health across the chronic condition spectrum. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we developed a novel approach that empowers individuals to adjust their lifestyle in a personalized way. Our Cross Functional Team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Already one of the highest rated diabetes solutions, its user-centric approach is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets.

Cautionary Note Regarding Forward-Looking Statements

This news release and the statements of representatives and partners of DarioHealth Corp. (the “Company”) related thereto contain or may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “plan,” “project,” “potential,” “seek,” “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” or “continue” are intended to identify forward-looking statements. For example, when the Company states that it sees clinics as ideal partners to scale up the growth of its user base and that tools such as the DarioEngage results in providers being able to deliver better clinical outcomes and meaningfully reduce the costs of chronic illness for the payer and the individual, it is using forward-looking statements. Readers are cautioned that certain important factors may affect the Company’s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect the Company’s results include, but are not limited to, regulatory approvals, product demand, market acceptance, impact of competitive products and prices, product development, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks, and the risks associated with the adequacy of existing cash resources. Additional factors that could cause or contribute to differences between the Company’s actual results and forward-looking statements include, but are not limited to, those risks discussed in the Company’s filings with the U.S. Securities and Exchange Commission. Readers are cautioned that actual results (including, without limitation, the timing for and results of the Company’s commercial and regulatory plans for Dario) may differ significantly from those set forth in the forward-looking statements. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

DarioHealth Corporate Contact:
Joao Mendes-Roter
VP Marketing
joao@mydario.com
+1-347-767-4220

View original content to download multimedia:http://www.prnewswire.com/news-releases/dariohealth-signs-leading-functional-medicine-clinic-to-darioengage-remote-digital-diabetes-platform-300821675.html

SOURCE DarioHealth Corp.